Devin Quinlan

Devin Quinlan's work experience begins with an internship at MPM BioImpact in September 2016, where they later transitioned into an associate role in June 2018 and then a senior associate role in January 2020. Currently, Devin holds the position of Principal at MPM BioImpact, starting in January 2023.

In addition to their work at MPM BioImpact, Devin served as a Director of Investment Initiative and a Graduate Director of Communications at MIT Biotech Group from April 2015 to December 2016. They were also a PhD Student and Graduate Research Assistant at Massachusetts Institute of Technology (MIT) from September 2012 to May 2018, where they also briefly worked as a Teaching Assistant from September 2013 to December 2013.

Furthermore, Devin worked as an Undergraduate Researcher in Dr. Daniel T. Kamei's Laboratory from March 2010 to June 2012. Most recently, Devin has taken on the role of Member, Board of Directors at NextPoint Therapeutics, Inc. starting in January 2023.

Devin Quinlan completed a B.S. in Bioengineering at UCLA from 2008 to 2012. They then pursued a Doctor of Philosophy (PhD) in Biological Engineering at the Massachusetts Institute of Technology from 2012 to 2018.